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A very efficient total synthesis of the apoptosis inducer (-)-
rasfonin has been developed using CuBr/JosiPhos catalyzed
iterative asymmetric conjugate addition of MeMgBr and
Feringa’s butenolide.
Natural products containing a-pyranones (d-lactones) show a
variety of interesting biological properties.1 As a prime example,
rasfonin 1, isolated from the fungus Trichurus terrophilus2 and
the fermented mycelium of Taleromyces species 3565-A1,3 has
been reported as an active apoptosis inducer in ras-dependent
cells.4 In connectionwith this ﬁnding, signiﬁcant proliferation sup-
pression of mouse splenic lymphocytes stimulated with mitogens,
concanavalin A and lipopolysaccharide, was reported.4
Due to the potential use of (-)-1 in the development of
cancer chemotherapeutics, a versatile synthetic route to rasfonin is
required to establish which parts of the molecule are important for
activity, and to pin down its target protein(s). The ﬁrst total synthe-
sis of (-)-1, reported by Ishibashi and co-workers in 2003, aimed at
structure elucidation and absolute conﬁguration determination.2,5
A second synthesis, reported by the group of Boeckman in 2006,6
was based on the use of camphor lactam chiral auxiliaries in order
to allow the synthesis of different stereoisomers. As no follow-
up appeared in chemical biology, we felt that a concise synthesis
of 1, taking advantage of highly efﬁcient and selective catalytic
methods and making this compound and analogs more readily
available, could greatly stimulate biological studies. Herein, we
report the asymmetric synthesis of (-)-1 in a highly efﬁcient and
selective manner.
In our retrosynthetic analysis (Scheme 1), (-)-rasfonin 1 was
disconnected into upper half 2 and lower half 3. The former
was planned to be obtained from 4, in turn prepared via our
iterative catalytic asymmetric conjugate addition protocol to
deoxypropionates,7 in combination with a stereospeciﬁc Achma-
towicz rearrangement. The lower part, 3, should in principle be
accessible starting from readily available enantiopure Feringa’s
menthyl butenolide 5.8
Syn-1,3-dimethyl thioester 4was synthesized in an excellent 57%
overall yield starting from ethylene glycol 6 by CuBr/JosiPhos
catalyzed iterative asymmetric conjugate addition of MeMgBr
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Scheme 1 Retrosynthesis of (-)-rasfonin 1.
(Scheme 2).9 Mono-protection of ethylene glycol 6 gave alcohol
7. IBX oxidation of alcohol 7 followed by Wittig reaction using
Wittig reagent 18 afforded substrate 9 in 86% yield. Substrate
9 gave excellent yield and enantioselectivity (95%, 95% ee) of
compound 10 using CuBr/JosiPhos catalyzed conjugate addition
ofMeMgBr.DIBAL reduction of compound 10 followed byHWE
oleﬁnation using reagent 19 gave thioester 11 in 89% yield. The
excellent syn selectivity (96 : 4) of the second asymmetric conjugate
addition of MeMgBr catalyzed by CuBr/JosiPhos gave dimethyl
Scheme 2 Synthesis of upper half of (-)-rasfonin 1.
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thioester 4 in 96% yield. Reduction of 4 with DIBAL afforded
the corresponding aldehyde which was used immediately to form
the terminal alkyne 12 by addition of lithiated trimethylsilyldia-
zomethane involving a Colvin rearrangement.10 Vinyl iodide 13
was subsequently prepared by Zr-catalyzed methylalumination,11
followed by Negishi cross coupling12 with ZnMe2 to afford alkene
14, which after deprotection with TBAF provided alcohol 15
in 87% yield. Ley oxidation13 of 15 afforded the corresponding
aldehyde which was treated with 2-furyl lithium to give the corre-
sponding furyl alcohol in 88% yield (syn : anti = 2 : 1). Subsequent
Ley oxidation of this mixture gave ketone 16 in 98% yield which
was in turn treated with (S)-CBS reagent and borane14 to afford
furyl alcohol 17 in an excellent 94% yield and a syn : anti ratio
>98 : 2. Stereospeciﬁc Achmatowicz rearrangement15 of 17 with
vanadyl acetylacetonate and tert-butylhydroperoxide afforded the
hemi-acetal in 69% yield which was subsequently oxidized by
Jones’ reagent16 to the corresponding ketolactone. Finally, Luche
reduction17 gave the upper half 2 as the only diastereomer.
The stereogenic center in the lower half of (-)-rasfonin was in-
troduced by Michael addition of lithium bis(phenylthio)methane8
to butenolide 5 to provide trans-20 as the single diastereomer in
86% yield (Scheme 3). Full reduction of 20 by LiAlH4 afforded
diol 21 in 90% yield which after protection provided 22 in
96% yield. Unmasking of dithiane 22 by HgCl2 and HgO in a
mixture of acetonitrile and water18 went smoothly and afforded
the free aldehyde in 85% yield which upon treatment with lithiated
trimethylsilyldiazomethane provided the terminal alkyne 23 in
67% yield. Terminal alkylation of the alkyne moiety to give 24
was performed by lithiation followed by quenching with methyl
iodide. The subsequent Pd-catalyzed hydrostannation of alkyne 24
with catalytic Pd(PPh3)Cl2 initially gave low yield and incomplete
conversion. We encountered this problem before,19 and again the
methodproposedbySemmelhack andHooley20 strongly improved
the outcome. Switching to catalytic Pd(OAc)2 and tricyclohexyl
phosphine, with hexane as the solvent, led to complete conversion
and 80% yield in 20 min! Vinyl iodide 25 was subsequently
obtained in 75% yield by treating this stannylated compound with
iodine. Stille coupling of acid 2621 and 25 provided lower half 3 in
87% yield.
Scheme 3 Synthesis of the lower half of (-)-rasfonin 1.
The coupling of the upper half 2 and lower half 3 of (-)-rasfonin
was achieved by Yamaguchi esteriﬁcation22 in 80% yield (Scheme
4). Desilylation initially was not satisfactory as treatment with
Scheme 4 Coupling of the upper half and lower half to give (-)-rasfonin
1.
camphorsulfonic acid gave only 40% yield.6 Fortunately, switching
to aq. HF in acetonitrile23 gave in a close to quantitative yield
(-)-rasfonin whose optical rotation and spectroscopic data agreed
with the reported values (except for the presence of approx. 5% of
a diastereomer that could not be separated).
In conclusion, a very efﬁcient total synthesis of the apoptosis
inducer (-)-rasfonin has been developed. CuBr/JosiPhos cat-
alyzed iterative asymmetric conjugate addition of MeMgBr has
been employed to install the stereogenic centers in the upper half
side chain with excellent yield and stereoselectivity. The hydroxy-
lactone core could be prepared by a subsequent stereospeciﬁc
hydroxy-directed Achmatowicz rearrangement followed by an
oxidation–reduction sequence. The synthesis of the lower half
3 makes use of the perfect transfer of chirality in the conjugate
addition to butenolide 5 followed by selective construction of
the E,E-diene-ester part. The availability of an effective route to
rasfonin now allows us to study its role in inhibiting the Ras
signalling pathway, provides access to functional analogs and
might lead to the identiﬁcation of its target protein.
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